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1. Introduction 
It has been demonstrated that certain n-substituted 
malonic acids have an inhibitory effect on the oxida- 
tion of di- and tri-carboxylate anions by rat liver mi- 
tochondria [l-3] . Thus the oxidations of citrate, iso- 
citrate, cis-aconitate and 2-oxoglutarate which are de 
pendent on the additon of Lmalate as an activator of 
mitochondrial penetration [l] were shown to be in- 
hibited by 2-n-butylmalonate, he inhibition being com- 
petitive with L-malate. The oxidations of L-malate 
with cysteine sulphinic acid and succinate, both depen- 
dent on the penetration of the mitochondria by a di- 
carboxylate anion, were also inhibited by 2-n-butyl- 
malonate [2]. The kinetics of the inhibition caused 
by butylmalonate indicated that its site of action was 
at the level of the membrane transporting system for 
dicarboxylate anions. When this inhibitor was used 
on rat heart mitochondria it was found to inhibit 
oxidations not requiring the transport of dicarboxy- 
late anions. These difficulties were partially overcome 
by the use of a new inhibitor, p-iodobenzylmalonate. 
2. Methods and materials 
Rat liver mitochondria were prepared as described 
previously [l] . Rat heart mitochondria were prepared 
by the method of Tyler and Gonze [4], except the 
preparation medium consisted of 0.25 M sucrose, 
5 mM tris HCl and 1 mM EGTA pH 7.4 and not that 
suggested by the above authors. Respiration was 
measured polarographically using a Clark oxygen elec- 
trode. Changes in intramitochondrial NAD(P) were 
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monitored fluorimetrically as described by Chappell 
and Crofts [S] .4,5,6,7-tetrachloro-2-trifluromethyl- 
benzimidazole (TTFB) wasa gift from Dr. R.B.Beechey 
(Shell Research, Sittingbourne, Kent, UK). 
Abbreviations used in this paper are TTFB as 
designated above and EGTA = ethylene-glycol-bis- 
(aminoethyl)-tetra-acetate. p-iodobenzylmalonic 
acid was purchased from K. and K. Rare Chemicals, 
Plainview, New York, USA. 2-n-butylmalonic acid 
was obtained from the City Chemical Corporation, 
New York, N.Y ., USA. 
3. Results 
3.1. Rat liver mitochondria 
Fig. 1 shows the oxidation of cis-aconitate by rat 
liver mitochondria s measured fluorimetrically by 
pyridine nucleotide reduction. Uncoupling agent 
(TTFB) was added so that the intramitochondrial 
NAD(P) became oxidized, followed three minutes 
later by antimycin to block the activity of the res- 
piratory chain. Cis-aconitate caused little reduction 
of intramitochondrial NAD(P) until Lmalate was 
added. When 0.8 mM butylmalonate was present he 
rate of reduction on the addition of Lmalate was 62% 
inhibited and with 0.8 mM p-iodobenzyhnalonate 
this rate was 72.5% inhibited. Fig.-2 shows a l/v 
against inhibitor concentration plot for the inhibition 
by p-iodobenzyhnalonate of isocitrate oxidation acti- 
vated by two different concentrations of L-malate 
measured at two different isocitrate concentrations 
(see Legend for details). This plot indicates that p 
iodobenzyl malonate inhibition is competitive with 
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Fig. 1. The inhibition of cis-aconitate oxidation by butyl- 
malonate and p-iodobenzylmalonate. Rat liver mitochondria 
(2 mg protein) were suspended in 3.0 ml of a medium con- 
taining 125 mM KCl, 20 mM tris HCl and 2 mM inorganic 
phosphate pH 7.4 at 3O’C. Pyridine nucleotide oxidation/ 
reduction changes were followed fluorimetrically. Only ex- 
periment A is shown in full since the initial oxidation of in- 
tramitochondrial pyridine nucleotides by uncoupling agent 
was the same for A, B and C. Additions were as follows: 
Expt. A. 4,5,6,7-tetrachloro-2-trfluoromethyl-benzimidazole 
(TTFB) 1 PM; antimycin, 0.2 &ml; cis-aconitate, 1.3 mM; 
L-malate 0.8 mM. Exp. B. Butylmalonate, 0.8 mM; TTFB, 
1 PM (not shown); antimycin, 0.2 &ml; cis-aconitate, 1.3 
mM; L-malate, 0.8 mM. Exp. C. p-iodobenzylmalonate, 0.8 
mM; TTFB, 1 PM (not shown); antimycin, 0.2 rg/ml; cis- 
aconitate, 1.3 mM; L-malate, 0.8 mM. 
respect to L-malate with aKi of 0.15 mM. Similar 
studies on butylmalonate inhibition gave a Ki of 0.35 
mM [2]. Butylmalonate has been shown to be a potent 
inhibitor of succinate oxidation in whole but not in 
broken rat liver mitochondria [2,6,7]. The Kl for 
butylmalonate was found to be 0.19 mM, but when 
iodobenzylmalonate was used a Kl of 0.08 mM was 
obtained. When oxidation of glutamate, (3 mM) by 
rat liver mitochondria was monitored polarographi- 
tally no inhibition of respiration was caused by 2 mM 
butylmalonate or 2 mM p-iodobenzylmalonate. 
3.2. Rat heart mitochondria 
In the case of rat heart mitochondria the tricar- 
boxylate anion transporting system activated by L 
malate is relatively inactive [8] so this sensitive 
method of observing inhibition of dicarboxylate anion 
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Fig. 2. The kinetics of p-iodobenzylmalonate inhibition of 
L(+)-isocitrate oxidation in the presence of L-malate. The 
reciprocal of the velocity of intramitochondrial NAD(P) re- 
duction by isocitrate in the presence of L-malate is plotted 
against inhibitor concentration under three sets of conditions. 
Rat liver mitochondria (2 mg protein) were suspended in 3.0 ml 
of a medium containing 125 mM KCl, 20 mM tris HCl and 
2 mM inorganic phosphate pH 7.4 at 3O’C. 1 PM TTFB was 
added and after three minutes 0.2 r&ml antimycin followed 
by p-iodobenzylmalonate (final concentrations hown), iso- 
citrate and L-malate. The rate of intramitochondrial NAD(P) 
reduction on the addition of L-malate was monitored fluor- 
imetrically. The three sets of conditions were: (a) 322 $vf 
L(+)-isocitrate, 129 nM L-malate (o-o); (b) 322 PM L(+)- 
isocitrate, 645 PM L-malate (a---~) and (c) 60.5 PM L(+)- 
isocitrate, 645 nM L-malate (e-e). 
entry by subsituted malonates was not available. As 
with liver mitochondria, butylmalonate was found to 
inhibit succinate oxidation in whole but not in broken, 
mitochondria. However it was also found that butyl- 
malonate inhibited the oxidation of both pyruvate 
and Lacetylcarnitine by rat heart mitochondria neither 
oxidation involving the transport of a dicarboxylate 
anion for the functioning of the Krebs cycle. This in- 
hibition could be relieved by the addition of Lmalate. 
p-Iodobenzylmalonate did not inhibit pyruvate and L 
acetyl carnitine oxidation to the same extent as butyl- 
malonate when used at concentrations capable of in- 
hibitory succinate oxidation to the same extent as 
butylmalonate, table 1. Thus, while 2 mM butylmal- 
onate inhibited succinate oxidation to the same extent 
as 0.75 mM p-iidobenzylmalonate, it inhibited pyruvate 
oxidation 68% while 0.75 mM p-iodobenzylmalonate 
inhibited pyruvate oxidation 14%. On this basis of com- 
paring other effects in relation to inhibitory potency 
to dicarboxylate transport butylmalonate inhibits suc- 
cinate oxidation in broken mitochondria 7% and p- 
iodobenzylmalonate 3.5%. 
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Table 1 
The inhibition of rat heart mitochondrial oxidations by 2-n-butylmalonate and piodo-benzylmalonate. 
Substrate 2-n- Butylmalonate 
Concn. % Inhibition 
(mM) 
p-Iodobenzyhnalonate 
Concn. % Inhibition 
(mM) 
Expt. A 
2.5 mM Pyruvate 
2.5 mM Acetylcarnitine 
3 mM Succinate 
Expt. B 
5 mM Succinate 
Broken mitochondria 
5 mM Succinate 
2 68% 0.75 14% 
2 87% 0.75 15% 
2 58% 0.75 54% 
2.5 66% 0.91 71% 
2.5 7.0% 0.91 3.5% 
Rat heart mitochondria (2.5 mg protein) were added to 2 ml of a medium containing 125 mM KCl, 20 mM tris HCI and 5 mM 
inorganic phosphate pH 7.4 at 25OC. The substrate was added at the concentrations hown followed by 1 mM ADP. When a linear 
rate had been obtained the inhibitor was added at the concentrations hown. The linear rate achieved after the addition of inhi- 
bitor was measured and used to calculate the percentage inhibition above. In experiments with succinate, 1 PM rotenone was used. 
For the broken mitochondrial experiments 0.06% Triton-X-100 was added to the mitochondrial suspension and 0.1 mg/ml phen- 
azine methosulphate as an autoxidisable lectron acceptor from succinate dehydrogenase. 
The Ki values for inhibition of succinate oxidation 
in whole rat heart mitochondria were found to be 
0.15 mM and 0.08 mM respectively for butylmalonate 
and p-iodobenzylmalonate. 
4. Discussion 
The lower Ki values found for p-iodobenzylmalonate 
with respect to Lmalate activation of tricarboxylate 
anion oxidation and with respect to succinate oxidation 
indicate that this is a better inhibitor of dicarboxylate 
anion transport than 2-n butylmalonate. The Ki values 
for the above mentioned oxidations may also indicate 
that the dicarboxylate anion transporting system in 
both liver and heart mitochondria has more affinity 
for L-malate than for succinate since lower Ki values 
are evident for succinate oxidation than for L-malate 
activated isocitrate oxidation. 
The inhibition of pyruvate and acetylcarnitine oxi- 
dation in heart mitochondria by butylmalonate was 
probably a result of competition of the inhibitor with 
succinate for succinate dehydrogenase. Since these 
oxidations are dependent on a supply of four carbon 
skeletons to citrate synthase, inhibition of succinate 
dehydrogenase would limit the flow through the 
Krebs cycle to malate and oxaloacetate thus pre- 
venting the oxidation. This would be relieved by the 
addition of L-malate. Although butylmalonate is 
essentially a mitochondrial non-penetrant [2] and a 
poor inhibitor of succinate dehydrogenase small 
amounts getting into heart mitochondria might cause 
an inhibition of succinate dehydrogenase significant 
enough to prevent the Krebs cycle from turning at its 
normal rate with these substrates. p-iodobenzylmal- 
onate, although having a superior affinity for the 
transporting system compared to butylmalonate does 
not prevent the cyclical oxidation of pyruvate and 
acetylcarnitine when used at concentrations inhibi- 
tory to dicarboxylate anion transport. Since butyl- 
malonate is now being tested on perfused tissues [lo] , 
we thought it useful to point out some of the dis- 
advantages of the use of butylmalonate. 
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